Download presentation
Presentation is loading. Please wait.
Published byVirginia Taylor Modified over 9 years ago
1
Doing more with less: New Zealand’s response to the health care sustainability challenge Toni Ashton Professor in health economics School of Population Health, University of Auckland School of Population Health
2
Average spending on health per capita ($US PPP)
3
Real growth in public health expenditure 1950 - 2010
4
New ZealandNetherlands % GDP on health (2010)10.112.0 Expenditure per capita (US$PPP ) 30225056 Annual growth rate 2000- 20105.5%5.4% Physicians per 10002.62.9 Nurses per 1000108.4 Hospital beds per 10002.74.7 Pharm. Expenditure per cap (US$PPP) 285481 Source: OECD Health Data 2012 Inputs
5
New ZealandNetherlands Doctor consults per year2.96.6 MRI exams per 10003.649.1 CT scans per 100022.466.0 Hospital discharges per 100014691158 Caesarean sections per 1000235148 Outputs Source: OECD Health Data 2012
6
NZ health system n 82% public funding (74% tax, 8% SI) n Risk-adjusted population-based regional funding n Free care in public hospitals - specialists salaried n GPs paid by capitation + copayments n Supplementary private insurance n Strong central guidance
7
Waves of “reform” in NZ n 1938: –Introduction of public health system –Locally-elected hospitals boards n 1993: –Purchaser/provider split and provider competition –Commercialisation of hospitals n 2000: –Back to locally-elected district health boards –Emphasis on primary health care
8
Public Hospitals Ministry of Health 20 District Health Boards “Service agreements” Ownership Accident Compensation Corporation PHOs, NGOs, Other private providers Population-based Funding
9
“While many developed countries are freezing or reducing health funding, this government is committed to protecting and growing our public health services.........” Budget May 16 2013 NZ$1.6 billion extra over next 4 years
10
“ We need to see further improvement in efficiency gains and containing costs..... We must do more with less”
11
Doing more with less: Macro (policy) level n Regionalisation/centralisation –Regional planning –Regional provider networks –Regional procurement of supplies –Centralisation of DHB ‘back office’ functions, IT, workforce –Fewer DHBs?? n HTA and prioritisation n Extension of PHARMAC to medical devices
13
Impact of PHARMAC on drug expenditure
14
Meso (organisational) level n Concentration of specialised hospital services n Shift of care from hospitals into the community n Improved integration of services
15
Integrated Family Health Centres: The vision Co-location of a wide range of services provided by multi-disciplinary teams –Minor surgery –Walk-in clinic –Nurse-led clinics for chronic care –Full diagnostics –Specialist assessments –Allied health services –Some social care
16
n Development patchy – and slow n Lack of start-up capital n Collaboration more important than co-location Integrated Family Health Centres: The practice
17
Meso (organisational) level n Concentration of specialised hospital services n Shift of care from hospitals into the community n Improved integration of services n Productivity of hospital wards
18
Productivity of public hospitals Productivity Med and Surg outputs Doctors and nurses
19
“Releasing time to care” n Time spent with patients increased by over 10%. Sometimes doubled. n Cost savings: eg: reduced stock levels, laundry n Fewer patient complaints, increased patient safety, improved staff morale
20
Meso (organisational) level n Concentration of specialised hospital services n Shift of care from hospitals into the community n Improved integration of services n Productivity of hospital wards n Long term care
21
New ZealandNetherlands Pop >65 years13.5%15.2% Pop >80 years3.4%3.9% 65+ in residential care3.6%6.7% 65+ receiving home care11.6%12.9% %GDP on long-term care1.4%3.5% Long-term care Source: OECD
22
Long-term care n “Aging in place” n Standardised needs-assessment n Assisted living arrangements?? n Stricter income and asset testing?? n Increase pre-funding?? –Compulsory insurance –Incentives for private saving
23
Micro-level (doctors and patients) n Task-shifting –Nurses, pharmacists, physician assistants n Improve patient self-management n Prevention –CVD and diabetes risk assessment –Immunisation –Smoking
24
What is NOT being discussed? n Increasing copayments n Greater use of private insurance n Increasing competition and choice n Methods of reducing “unneccessary” care
25
Dank u wel!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.